Latest Macular degeneration Stories
- AIMing to establish a new treatment for ophthalmologic diseases - TOKYO, Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma Inc.
MOUNTAIN VIEW, Calif., Oct.
Easy to use "Oral Strips" Solve Improper Dosing and Pill-Swallowing Issues for Patients Relying on Nutraceuticals to Preserve Ocular Health BIRMINGHAM, Ala., Oct.
SARATOGA, Calif., Oct. 13, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc.
Findings help product development at Diopsys, Inc. Pine Brook, NJ (PRWEB) October 10, 2014 Research scientists from the University of Alabama, Birmingham
New study shows that the Diopsys NOVA-ERG acts as window to the brain Pine Brook, NJ (PRWEB) October 09, 2014 Research scientists from the University
HUNTINGTON, N.Y., Oct.
-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since
EYLEA Now Approved for Wet Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and Macular Edema following RVO TARRYTOWN, N.Y., Oct.
SAN DIEGO, Sept.
- To fire mitraille at.